These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18292687)

  • 1. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
    Boström E; Hammarlund-Udenaes M; Simonsson US
    Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
    Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
    Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Sadiq MW; Salehpour M; Forsgard N; Possnert G; Hammarlund-Udenaes M
    Drug Metab Dispos; 2011 Feb; 39(2):174-9. PubMed ID: 21059857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier transport of morphine in patients with severe brain trauma.
    Ederoth P; Tunblad K; Bouw R; Lundberg CJ; Ungerstedt U; Nordström CH; Hammarlund-Udenaes M
    Br J Clin Pharmacol; 2004 Apr; 57(4):427-35. PubMed ID: 15025740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.
    Sadiq MW; Boström E; Keizer R; Björkman S; Hammarlund-Udenaes M
    J Pharm Sci; 2013 Sep; 102(9):3320-31. PubMed ID: 23463542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
    Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
    Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrations.
    Gustafsson S; Eriksson J; Syvänen S; Eriksson O; Hammarlund-Udenaes M; Antoni G
    Neuroimage; 2017 Jul; 155():177-186. PubMed ID: 28467891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
    Okura T; Higuchi K; Deguchi Y
    Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
    Fridén M; Winiwarter S; Jerndal G; Bengtsson O; Wan H; Bredberg U; Hammarlund-Udenaes M; Antonsson M
    J Med Chem; 2009 Oct; 52(20):6233-43. PubMed ID: 19764786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?
    Hammarlund-Udenaes M
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):215-20. PubMed ID: 20050843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone.
    Ball K; Bouzom F; Scherrmann JM; Walther B; Declèves X
    J Pharm Sci; 2012 Nov; 101(11):4277-92. PubMed ID: 22864977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study.
    Bällgren F; Hammarlund-Udenaes M; Loryan I
    Pharm Res; 2023 Nov; 40(11):2715-2730. PubMed ID: 37610619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
    Bundgaard C; Jørgensen M; Larsen F
    Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia.
    Lemberg KK; Siiskonen AO; Kontinen VK; Yli-Kauhaluoma JT; Kalso EA
    Anesth Analg; 2008 Feb; 106(2):463-70, table of contents. PubMed ID: 18227301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Diuretics have Antinociceptive Actions: Studies of Spironolactone, Eplerenone, Furosemide and Chlorothiazide, Individually and with Oxycodone and Morphine.
    Jokinen V; Lilius T; Laitila J; Niemi M; Kambur O; Kalso E; Rauhala P
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):38-45. PubMed ID: 27312359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative investigation of the brain-to-cerebrospinal fluid unbound drug concentration ratio under steady-state conditions in rats using a pharmacokinetic model and scaling factors for active efflux transporters.
    Kodaira H; Kusuhara H; Fuse E; Ushiki J; Sugiyama Y
    Drug Metab Dispos; 2014 Jun; 42(6):983-9. PubMed ID: 24644297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux.
    Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
    Br J Pharmacol; 2007 Jul; 151(5):701-12. PubMed ID: 17471182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.